Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine-based Conditioning in Severe Aplastic Anemia
NCT00326417Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Jan 2006
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in aplastic anemia, sponsored by Medical College of Wisconsin. Started Jan 2006; status: completed.
02
Drugs
fludarabine
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT00326417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326417.